Diabesity has become a public health problem threatens human health.Diabesity remission could prevent patients from using anti-diabetic drugs for a certain period of time,reduce their psychological burden,enhance their confidence in following a healthy lifestyle,and delay the progression of complications.Currently,lifestyle intervention and blood sugar control are the main methods for diabesity remission.The treatment of TCM has a systematic theoretical basis and positive clinical efficacy for diabesity,significantly improving life quality of patients.Consequently,according to the latest guidelines,consensus and research progress of traditional Chinese and Western medicine at home and abroad,a consensus on integrated traditional Chinese and Western medicine to alleviate diabesity has been formed.The consensus standardized the diagnosis and treatment of diabesity in Western medicine,as well as the differentiation of TCM syndromes,principles,prescriptions and health management,to assist clinical doctors in both TCM and Western medicine in carrying out standardized work to alleviate diabesity.

Diabesity has become a public health problem threatens human health.Diabesity remission could prevent patients from using anti-diabetic drugs for a certain period of time,reduce their psychological burden,enhance their confidence in following a healthy lifestyle,and delay the progression of complications.Currently,lifestyle intervention and blood sugar control are the main methods for diabesity remission.The treatment of TCM has a systematic theoretical basis and positive clinical efficacy for diabesity,significantly improving life quality of patients.Consequently,according to the latest guidelines,consensus and research progress of traditional Chinese and Western medicine at home and abroad,a consensus on integrated traditional Chinese and Western medicine to alleviate diabesity has been formed.The consensus standardized the diagnosis and treatment of diabesity in Western medicine,as well as the differentiation of TCM syndromes,principles,prescriptions and health management,to assist clinical doctors in both TCM and Western medicine in carrying out standardized work to alleviate diabesity.

Objective To observe the inhibitory effect of ethanol extract of Cassia mimosoides Linn. (EE-CML) on dimethylnitrosamine-induced hepatic fibrosis in rats and to explore its therapeutic mechanism. Methods Sixty male SD rats were equally divided into 6 groups: normal group, model group, high-, middle-and low-dose EE-CML groups (at the doses of 12.6 g/kg, 4. 2 g/kg, and 1.4 g/kg respectively) and colchicine (0. 2 mg/kg). Intervention treatment with EE-CML by gastric gavage was carried out in the rats with hepatic fibrosis which was induced by dimethylnitresamine simulta-neously and their effects were compared with the group treated with colchicine. The model group and the normal group were giv-en the same volume of saline once a day. Four weeks after treatment, hepatic function, levels of serum hyaluronic acid (HA), serum laminin (LN), serum aminoterminal propeptide of type Ⅲ procollagen (PCⅢ), hepatic hydroxyproline (Hyp), and histopathological changes in rats were assayed and examined. Results Compared with those in the model group, in the differences of serum alanine aminotransferase (ALT) level in three EE-CML groups and serum aspartate aminotrans-ferase (AST) level in high dose EE-CML group were statistically significant (P < 0. 05) ; hepatic Hyp level and serum HA, LN and PCⅢNP contents in EE-CML groups were significantly lower than those in the model group (P < 0. 05). Hepatic fi-brosis of rats in EE-CML groups alleviated significantly, and the differences compared with that in the model group were sta-tistically significant (P < 0. 05). Conclusion Ethanol extract of Cassia mimosoides shows significant inhibitory effect on the dimethylnitrosamine-induced hepatic fibrosis in rats, and the inhibitory mechanism may be related to the protection on hepatic cells and the inhibition on collagen fiber synthesis.

Objective To identify the volatile chemical components of cassia mimosoides. Method The volatile components were distilled with steam distillation,and then their compounds were confirmed by GC-MS. Results Fifteen peaks were detected by GC-MS,and 14 components of them were identified. The identified compounds occupied 98.97% of the volatile oil. The main component is 6,10,14-trimethyl-2-pentadecanone (43.86%),then is phytol (36.54%).Conclusion 6,10,14-trimethyl-2-pentadecanone can be used for the identification of this plant.

Objective To observe the inhibitory effect of ethanol extract of Cassia mimosoides Linn. (EE-CML) on dimethylnitrosamine-induced hepatic fibrosis in rats and to explore its therapeutic mechanism. Methods Sixty male SD rats were equally divided into 6 groups: normal group, model group, high-, middle-and low-dose EE-CML groups (at the doses of 12.6 g/kg, 4.2 g/kg, and 1.4 g/kg respectively) and colchicine (0.2 mg/kg). Intervention treatment with EE-CML by gastric gavage was carried out in the rats with hepatic fibrosis which was induced by dimethylnitrosamine simultaneously and their effects were compared with the group treated with colchicine. The model group and the normal group were given the same volume of saline once a day. Four weeks after treatment, hepatic function, levels of serum hyaluronic acid (HA), serum laminin (LN), serum aminoterminal propeptide of type III procollagen (PCIII), hepatic hydroxyproline (Hyp), and histopathological changes in rats were assayed and examined. Results Compared with those in the model group, in the differences of serum alanine aminotransferase (ALT) level in three EE-CML groups and serum aspartate aminotransferase (AST) level in high dose EE-CML group were statistically significant (P